Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03016975 · ClinicalTrials.gov registry record · NA
Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)
A NA study, sponsored by Edwards Lifesciences.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03016975 is a NA study that was terminated before completion, run by Edwards Lifesciences. The registered enrollment target is 12 participants.
The verdict
NCT03016975, a NA study, was terminated before completion, sponsored by Edwards Lifesciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
To establish the safety and effectiveness of the Edwards Cardioband System in patients with functional mitral regurgitation (FMR).
Interventions
- DEVICE Edwards Cardioband System
- DRUG Guideline Directed Medical Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2022-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03016975
The ClinicalTrials.gov registry entry for NCT03016975 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Edwards Cardioband System is the first listed.
NCT03016975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03016975 about?
NCT03016975 is a clinical study titled "Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)". To establish the safety and effectiveness of the Edwards Cardioband System in patients with functional mitral regurgitation (FMR).
What is the current status of trial NCT03016975?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2017-06-01. Estimated completion is 2022-09-20.
What interventions are being tested in trial NCT03016975?
The interventions under investigation include: Edwards Cardioband System (DEVICE), Guideline Directed Medical Therapy (DRUG).
Who is sponsoring clinical trial NCT03016975?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.